Don’t let the high cost of brand trientine for Wilson’s disease disrupt your copper-chelation therapy. We help eligible patients access Syprine (trientine hydrochloride capsules) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
The Syprine Patient Assistance Program is a manufacturer-sponsored initiative that helps eligible patients access Syprine (used for the treatment of Wilson’s disease in patients intolerant of penicillamine) at little or no cost when they meet specific income, insurance, and clinical criteria. The program is free to apply for, but the enrollment process involves detailed applications, hepatology coordination, biochemical and genetic documentation of Wilson’s disease diagnosis, evidence of penicillamine intolerance, supporting documentation, and ongoing renewal — which can be overwhelming when you are managing a rare lifelong inherited metabolic disorder.
At AffordMyPrescriptions, our Patient Advocates handle the entire Syprine PAP enrollment for a flat $69.95 per month. We complete the application, coordinate with your hepatologist for required medical documentation (typically including ceruloplasmin levels, 24-hour urinary copper, hepatic copper quantification or genetic testing, and documented penicillamine intolerance), follow up with the manufacturer’s program until approval, manage your refills, and handle annual re-certification — so you never face a gap in your Syprine Wilson’s disease therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Syprine enrollment — from the initial application through ongoing refills and annual re-enrollment — so you never face a gap in your Wilson’s disease treatment.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$28,000/mo | Save substantially |
| CVS Pharmacy(brand) | ~$30,000/mo | Save substantially |
| Walmart(brand) | ~$22,000/mo | Save substantiallySave ~$335/mo |
| Specialty pharmacy (brand) | ~$20,000/mo | Save substantially |
| Generic trientine HCl | ~$2,500/mo | Generic — substantial |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Syprine — independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Syprine Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management — applications that are commonly delayed or denied when paperwork is incomplete. Our $69.95 per month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork. Generic trientine hydrochloride now offers substantial cost reduction, and generic zinc sulfate is a very inexpensive maintenance-phase option after initial decoppering.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Syprine:
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $20,000–$30,000 per month even with the best discount
Fixed $69.95/month — never changes regardless of retail price
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
If denied, we explore alternative savings paths on your behalf
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Syprine assistance.
Syprine is the brand trientine — a copper chelator used in Wilson’s disease patients who cannot tolerate penicillamine (Cuprimine). Trientine forms stable complexes with copper that are excreted in urine, reducing the systemic copper overload that causes hepatic, neurologic, psychiatric, and hematologic manifestations of Wilson’s disease. Lifelong therapy is essential.
How Syprine works:
Wilson’s disease is an inherited (autosomal recessive) disorder of copper transport — mutations in ATP7B impair biliary copper excretion and copper incorporation into ceruloplasmin. Copper accumulates in liver, brain, eyes (Kayser-Fleischer rings), kidneys, and other tissues, causing hepatitis, cirrhosis, neuropsychiatric symptoms, and hemolytic anemia.
Trientine chelates copper — forms a complex excreted in urine. Reduces tissue copper accumulation and reverses or stabilizes organ dysfunction over months to years. Used either as initial decoppering therapy or for chronic management. Penicillamine (Cuprimine) is the traditional first-line chelator; trientine is preferred when penicillamine is not tolerated (rash, leukopenia, proteinuria, neuropathy).
Form and use:
Syprine 250 mg capsules. Adult initial dose 750–1,250 mg/day in 2–4 divided doses; may increase to 2,000 mg/day maximum. Pediatric (<12 years) 500–750 mg/day in 2–4 divided doses; up to 1,500 mg/day. **Take on empty stomach — at least 1 hour before or 2 hours after meals, and at least 1 hour from any other drug, food, or milk** (copper, iron, and other minerals impair absorption). Refrigerate.
Syprine 250 mg capsules. Adult initial dose 750–1,250 mg/day in 2–4 divided doses; may increase to 2,000 mg/day maximum. Pediatric (<12 years) 500–750 mg/day in 2–4 divided doses; up to 1,500 mg/day. **Take on empty stomach — at least 1 hour before or 2 hours after meals, and at least 1 hour from any other drug, food, or milk** (copper, iron, and other minerals impair absorption). Refrigerate. Lifelong therapy. Monitor 24-hour urinary copper (target reflects therapeutic response), hepatic function, neuropsychiatric symptoms, CBC.
Generic availability:
**Generic trientine hydrochloride now available** from some manufacturers (Aurobindo, Teva — substantial savings vs brand Syprine). Trientine tetrahydrochloride (Cuvrior — brand, newer FDA-approved 2022) — different formulation with simpler dosing. Other Wilson’s disease therapies: penicillamine (Cuprimine — first-line copper chelator per AASLD guidelines, requires pyridoxine supplementation), zinc acetate (Galzin — brand) and generic zinc sulfate (induces enterocyte metallothionein to block dietary copper absorption, used for maintenance and presymptomatic patients), tetrathiomolybdate (Wilzin — outside US, dual mechanism of decoppering and copper-protein binding). **Diet:** avoid copper-rich foods (shellfish, organ meats, nuts, mushrooms, chocolate, dried fruits) especially during decoppering phase. Definitive treatment: liver transplantation for fulminant Wilsonian hepatitis, advanced cirrhosis, or treatment-refractory disease. Family screening (genetic and biochemical) for all first-degree relatives is essential.
Warnings:
Iron deficiency anemia (trientine chelates iron — supplement iron 2 hours away from trientine doses), gastritis, abdominal pain, nausea (improves with continued use), worsening neurologic symptoms during initial decoppering (temporary neurological deterioration — usually transient but can be severe), lupus-like reactions (rare), proteinuria and renal effects (monitor urinalysis), hepatotoxicity (rare). Take on empty stomach away from food, milk, antacids, mineral supplements (impair absorption). Use during pregnancy: limited data — pregnancy planning critical; Wilson’s disease requires continuous treatment during pregnancy with hepatology coordination. Lactation: limited data.
Brand Syprine $20,000–$30,000 per month — among the most expensive medications in the United States due to limited competition and rare-disease pricing. **Generic trientine hydrochloride now available — substantial savings ($2,000–$4,000 per month range).** Generic zinc sulfate (maintenance phase option) is very inexpensive at $10–$20 per month.
Wilson’s disease is an inherited disorder of copper metabolism — patients accumulate copper in the liver, brain, eyes, and other organs, causing hepatitis, cirrhosis, neuropsychiatric symptoms, and hemolytic anemia. Without continuous copper chelation or zinc-mediated blockade of copper absorption, copper re-accumulates and tissue damage progresses. Lifelong treatment is essential and stopping therapy can lead to fulminant hepatic failure.
Generic trientine hydrochloride is FDA-approved bioequivalent. Same active ingredient, same effect on copper chelation. Substantial cost savings with generic. Discuss with your hepatologist; insurance increasingly favors generic.
Food (especially copper-containing foods, dairy, and mineral-rich foods) and other medications/supplements substantially impair trientine absorption. Take at least 1 hour before or 2 hours after meals, and away from iron, zinc, and other mineral supplements by at least 1 hour.
Both are copper chelators for Wilson’s disease. Penicillamine (Cuprimine) is the AASLD-recommended first-line chelator but has frequent intolerance issues (rash, fever, leukopenia, proteinuria, neuropathy). Trientine (Syprine) is preferred when penicillamine cannot be tolerated. Both require pyridoxine supplementation with penicillamine specifically; trientine often better-tolerated long-term.
24-hour urinary copper (target reflects therapeutic response — should fall over months), liver enzymes and synthetic function (INR, albumin), CBC (check for anemia from iron chelation), urinalysis (proteinuria), neurologic assessment for symptom changes (worsening during initial decoppering is recognized), and ceruloplasmin levels periodically.
Yes — liver transplantation provides a normal ATP7B gene product and effectively cures Wilson’s disease. Reserved for fulminant Wilsonian hepatitis, advanced decompensated cirrhosis, or treatment-refractory neurologic disease. Most patients are managed long-term with chelation or zinc therapy.
We help explore **generic trientine hydrochloride (substantial savings)**, penicillamine (Cuprimine) if previously not adequately tried (generic limited; brand expensive), zinc therapy for maintenance phase (generic zinc sulfate is very cheap), Cuvrior (trientine tetrahydrochloride) copay programs, rare disease foundations (Wilson Disease Association, NORD), Patient Access Network, Patient Advocate Foundation, NeedyMeds, hepatology center copper disease specialty programs, and liver transplant evaluation for advanced disease.
Wilson’s disease lifelong therapy should not be derailed by cost. Generic trientine offers substantial savings, and zinc therapy provides very inexpensive maintenance options. Our Syprine advocacy team is ready to verify your eligibility, complete the manufacturer application on your behalf, and manage your prescription through approval, delivery, and renewal — for a flat $69.95 per month. If we cannot help you access Syprine through a Patient Assistance Program, you are not charged. Call (833) 556-2729 or check your eligibility online today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.